Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00338-1 ◽

2021 ◽

Author(s):

David T Rubin ◽

Iris Dotan ◽

Aaron DuVall ◽

Yoram Bouhnik ◽

Graham Radford-Smith ◽

...

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Randomised Controlled Trials ◽

Controlled Trials ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Two Phase ◽

Randomised Controlled

OP019. Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate-to-severe ulcerative colitis: results from 2 phase 3 randomised controlled trials

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.018 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S15.1-S15 ◽

Cited By ~ 1

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Randomised Controlled Trials ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Randomised Controlled

767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials

Gastroenterology ◽

10.1016/s0016-5085(16)30622-9 ◽

2016 ◽

Vol 150 (4) ◽

pp. S157 ◽

Cited By ~ 7

Author(s):

William Sandborn ◽

Bruce E. Sands ◽

Geert R. D'Haens ◽

Severine Vermeire ◽

Stefan Schreiber ◽

...

Keyword(s):

Ulcerative Colitis ◽

Randomized Controlled Trials ◽

Induction Therapy ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Severe Ulcerative Colitis ◽

Randomized Controlled

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30427-2 ◽

2019 ◽

Vol 7 (3) ◽

pp. 213-226 ◽

Cited By ~ 44

Author(s):

Charles S Haworth ◽

Diana Bilton ◽

James D Chalmers ◽

Angela M Davis ◽

Juergen Froehlich ◽

...

Keyword(s):

Cystic Fibrosis ◽

Pseudomonas Aeruginosa ◽

Randomised Controlled Trials ◽

Lung Infection ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Randomised Controlled ◽

Chronic Lung Infection

Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments

The American Journal of Gastroenterology ◽

10.14309/00000434-201610001-00709 ◽

2016 ◽

Vol 111 ◽

pp. S319-S320 ◽

Cited By ~ 2

Author(s):

Brian Feagan ◽

Séverine Vermeire ◽

William J. Sandborn ◽

Walter Reinisch ◽

Dino Tarabar ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trials ◽

Induction Therapy ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Two Phase

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30412-4 ◽

2020 ◽

Author(s):

Christopher E Brightling ◽

Mina Gaga ◽

Hiromasa Inoue ◽

Jing Li ◽

Jorge Maspero ◽

...

Keyword(s):

Severe Asthma ◽

Randomised Controlled Trials ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Randomised Controlled

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13876 ◽

2016 ◽

Vol 45 (2) ◽

pp. 240-252 ◽

Cited By ~ 30

Author(s):

H. Miwa ◽

N. Uedo ◽

J. Watari ◽

Y. Mori ◽

Y. Sakurai ◽

...

Keyword(s):

Clinical Trial ◽

Randomised Controlled Trials ◽

Randomised Clinical Trial ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Duodenal Ulcers ◽

Gastric Or Duodenal Ulcers ◽

Randomised Controlled

Faculty of 1000 evaluation for Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717949380.793470216 ◽

2013 ◽

Author(s):

Eduard Stange

Keyword(s):

Ulcerative Colitis ◽

Randomised Controlled Trials ◽

Pooled Analysis ◽

Controlled Trials ◽

Once Daily ◽

Randomised Controlled

Faculty Opinions recommendation of Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717949380.793454547 ◽

2012 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Ulcerative Colitis ◽

Randomised Controlled Trials ◽

Pooled Analysis ◽

Controlled Trials ◽

Once Daily ◽

Randomised Controlled

Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials

The Lancet Rheumatology ◽

10.1016/s2665-9913(19)30103-1 ◽

2020 ◽

Vol 2 (1) ◽

pp. e31-e41

Author(s):

Tove Hegelund Myrbäck ◽

Susanne Prothon ◽

Karl Edman ◽

Jacob Leander ◽

Mahdi Hashemi ◽

...

Keyword(s):

Glucocorticoid Receptor ◽

Healthy Volunteers ◽

Randomised Controlled Trials ◽

Phase 1 ◽

Controlled Trials ◽

Two Phase ◽

Receptor Modulator ◽

Randomised Controlled ◽

Single Blind

P162 Induction of clinical and endoscopic remission with budesonide MMX in mild to moderately active ulcerative colitis: Pooled data from two phase 3 studies

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(12)60182-2 ◽

2012 ◽

Vol 6 ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

S. Travis ◽

S. Danese ◽

L. Moro ◽

E.D. Ballard ◽

R. Bagin ◽

...

Keyword(s):

Ulcerative Colitis ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Two Phase ◽

Pooled Data ◽

Endoscopic Remission